. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Nov 11;151(3):815–23.e1-2. doi: 10.1016/j.jtcvs.2015.10.114

TABLE 2.

Perioperative morbidity and mortality for patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR)

	TAVR			SAVR

Event	No delirium (n = 119)	Delirium (n = 49)	P value	No delirium (n = 173)	Delirium (n = 86)	P value
Prolonged ventilation	2 (2)	0 (0)	>.999	10 (6)	18 (21)	<.001
Stroke	1 (1)	1 (2)	.500	1 (1)	1 (1)	>.999
Acute kidney injury	8 (7)	12 (24)	.003	25 (14)	15 (17)	.580
Initial intensive care unit stay (h)	26	50	<.001	31	72	<.001
Readmission to the intensive care unit	4 (3)	5 (10)	.120	2 (1)	9 (10)	.001
Hospital length of stay (d)	5	7	<.001	7	9	<.001
Discharged to home	87 (73)	26 (53)	.018	146 (84)	49 (57)	<.001
30-d survival (%)	98	88	.029	100	95	.040
1-y survival (%)	80	66	.090	97	83	.001

Values are presented as n (%) unless otherwise noted.

TAVR, Transcatheter aortic valve replacement; SAVR, surgical aortic valve replacement.